Search results for: “biotech”
-
Ashington Innovation agrees to acquire Calon Cardio-Technology for £39 million
•
LONDON, UK: Ashington Innovation plc has entered into a non-binding heads of terms agreement with Calon Cardio-Technology Limited,…
-
BiVictriX Therapeutics gets US Patent providing broad protection for BVX001
•
ALDERLEY PARK, LONDON: BiVictriX Therapeutics plc (AIM: BVX), an emerging biotechnology company applying a differentiated approach to develop…
-
Ashington Innovation to acquire Cell Therapy in a £135 million all-share deal
•
LONDON, UK: Ashington Innovation (LSE:ASHI), a SPAC that focuses on technology businesses, has announced that it has signed…
-
Clean Food Group secures £2.3 million funding to scale up sustainable oils and fats technology
•
LONDON, UK: Clean Food Group, a UK-based biotech company that produces sustainable oils and fats from food waste,…
-
Abivax announces plans to conduct registered public offering in the United States
•
PARIS, FRANCE: Abivax, a French biotechnology company that develops novel treatments for inflammatory diseases, viral diseases and cancer,…
-
Amyris files for bankruptcy, plans to sell consumer brands
•
Amyris, a biotech firm that produces sustainable ingredients for various industries, has filed for Chapter 11 bankruptcy protection…
-
Sir Nigel Rudd returns as Chairman of Destiny Pharma
•
LONDON, UK: Destiny Pharma plc (AIM: DEST), a clinical stage innovative biotechnology company focused on the development of…
-
Eli Lilly to buy Versanis for up to $1.93 billion in obesity drug push
•
Eli Lilly and Co said on Friday it will acquire Versanis, a privately held biotech company developing a…
-
Oncimmune announces new CEO and finance director as part of leadership shake-up
•
LONDON, UK: Oncimmune Holdings plc, a company that provides autoantibody profiling services to the pharma and biotech industry,…
-
Intuitive Investments Group appoints Sir Nigel Rudd as its next chairman
•
LONDON, UK: Intuitive Investments Group plc (IIG), a closed-end investment company focused on the life sciences sector, has…
-
Nanobiotix signs deal with Janssen for cancer drug NBTXR3
•
PARIS, FRANCE: Nanobiotix, a biotechnology company developing nanotherapeutics for cancer, has announced a global deal with Janssen Pharmaceutica…
-
Bitterroot Bio emerges from stealth with $145M to develop immunotherapies for heart disease
•
Bitterroot Bio, a biotech company that aims to develop immunotherapies for cardiovascular disease, has announced its emergence from…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.